Sensus Healthcare Inc (STU:5TX)

Q4 2024 Sensus Healthcare Inc Earnings Call Transcript

Feb 5, 2025 / 09:30 PM GMT

Release Date Price: €8.5 (+5.59%)

Transcript 8-K

Key Points

Positve

Sensus Healthcare Inc (SRTS) reported a 71% increase in annual revenue, reaching $41.8 million, driven by higher unit sales of their SRT 100 systems.
The company achieved its fifth consecutive quarter of profitability with a net income of $1.4 million for the fourth quarter.
Sensus Healthcare Inc (SRTS) ended the year with $22.1 million in cash and no debt, providing a strong capital position for future investments.
The Fair Deal Agreement program has gained significant traction, particularly among large dermatology groups and private equity-backed practices.
The company is expanding its international footprint, with 10 systems shipped internationally during the year, and exploring new markets such as veterinary medicine.

Negative

Gross profit margin decreased from 62.3% to 54.4% year-over-year due to a one-time discount and higher service costs.
General and administrative expenses increased significantly, mainly due to higher compensation and professional fees.
The company anticipates a potential decline in sales for the first quarter of 2025 compared to the first quarter of 2024.
There is a delay in revenue recognition from the Fair Deal Agreement placements, with contributions expected in the second half of 2025.
The company faces competition from traditional treatments like Mohs surgery, which remains a significant alternative in the dermatology market.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SRTS.OQ - Sensus Healthcare Inc
Q4 2024 Sensus Healthcare Inc Earnings Call
Feb 05, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the census healthcare fourth quarter, 2024 financial results conference call, all participants will be in listen-only mode. Should you need assistance? Please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions to ask a question. You may press star then one on your touchtone phone to withdraw your question. Please press star. Then two. Please note this event is being recorded. I would now like to turn the conference over to turf Hotel alliance advisors. I please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
---------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.